Saline (0.9% sodium chloride)

OTHER3 trials

Sponsors

Idorsia Pharmaceuticals Ltd., A.J.M. van den Eertwegh, Copenhagen University Hospital, Rigshospitalet

Conditions

HealhtyHealthy SubjectsMalignant MelanomaType 2 Diabetes

Phase 1

A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

CompletedNCT03596294

Idorsia Pharmaceuticals Ltd.Healthy Subjects

Start: 2018-07-19End: 2018-08-03Updated: 2018-10-23

Phase 2

A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma

RecruitingNCT04126876

A.J.M. van den EertweghMalignant Melanoma

Start: 2020-01-22End: 2031-11-01Target: 214Updated: 2021-04-15

Unknown Phase

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion

RecruitingNCT07398300

Copenhagen University Hospital, RigshospitaletHealhty, Type 2 Diabetes

Start: 2026-03-12End: 2027-05-01Target: 36Updated: 2026-10-27